Clinical and biochemical outcomes of Sodium-Glucose CoTransporter-2 (SGLT2) Inhibitors in Type-2 Diabetes Mellitus Patients as a fourth oral anti diabetic medicine

OBJECTIVES: To evaluate the clinical and biochemical effects of (SGLT2) inhibitors as a fourth oral anti-diabetic drug in patients with Type-2 diabetes mellitus (T2DM). METHODS: In a tertiary hospital in Karachi, Pakistan, a retrospective assessment of patient medical records was conducted from Janu...

Descripción completa

Detalles Bibliográficos
Autores principales: Saleem, Muhammad, Khan, Sajjad Ali, Suchal, Zafar Aleem, Ram, Nanik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247778/
https://www.ncbi.nlm.nih.gov/pubmed/35799740
http://dx.doi.org/10.12669/pjms.38.5.5034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247778/
https://www.ncbi.nlm.nih.gov/pubmed/35799740
http://dx.doi.org/10.12669/pjms.38.5.5034

Ejemplares similares